Partners and stakeholders within the PRECISEU ecosystem are invited to take part in a series of upcoming online sessions delivered through the Educational Entrepreneurship for Healthcare programme, developed by TUM Venture Labs.
These sessions are part of the broader GeneNovate programme, an initiative designed to support researchers, innovators and early-stage teams working in healthcare, life sciences and advanced therapies. The programme focuses on strengthening entrepreneurial skills and supporting the transition from research to application, covering key aspects such as regulation, business development, financing and go-to-market strategies.
Upcoming sessions
As of April 2026, the following sessions remain open for participation:
- Session 4 – 1 April 2026
Regulation, product/solution development, go-to-market strategies - Session 5 – 4 May 2026
Legal foundations, team & project management, partnerships - Session 6 – 1 June 2026
Financing & funding, investor discussions, exit strategies
Participants from the PRECISEU ecosystem can join one or more of these sessions as guests, depending on their interests and availability.
About GeneNovate
GeneNovate is part of the TUM Venture Labs’ Educational Entrepreneurship for Healthcare programme, which supports innovation in areas such as cell and gene therapies, digital health and personalised medicine. The programme brings together expertise from academia, industry and entrepreneurship to help participants better understand the pathway from scientific discovery to real-world application.
Through a combination of training sessions, expert input and practical insights, GeneNovate addresses key challenges faced by healthcare innovators, including regulatory pathways, funding strategies and building sustainable ventures.
How to join
To register, participants can use the “Apply now” button AVAILABLE HERE.
